About The Position
Reporting to the Director of Evidence Strategy and Access, Europe, within the Medical Affairs team. You will collaborate closely with Sales, Global Access Value and Economics, Clinical Affair, Governmental affairs, Marketing and Finance teams to develop robust frameworks for the assessment and appraisal of endoluminal robotics‑assisted technologies. Define and lead the Market Access strategy in France and Benelux, including: Pricing and reimbursement strategy Health economics, value demonstration and clinical evidence generation Access pathway optimization Adapt and scale successful approaches across other European markets, demonstrating flexibility to contribute to cross-country initiatives and business needs.
Requirements
- Strong adaptability and willingness to support cross-country initiatives, enabling effective scaling of approaches across European markets.
- Field reimbursement experience in Hospital setting
- A degree in health economics, public health, life sciences, or a related field (a postgraduate qualification is a plus).
- At least 5+ years of relevant experience in market access, health economics, or reimbursement, ideally in the MedTech sector, though pharma backgrounds will be considered.
- Strong understanding of the French healthcare, HAS processes (CNEDIMTS, CEESP) and reimbursement system (experience with Belgium and The Netherlands is a plus).
- Excellent data analysis skills, with experience in DRG coding, funding research, or policy monitoring.
- Fluent communication skills in both French and English, with the ability to present confidently and write clearly for professional audiences.
- Requires frequent travel (approximately 50-60%) across the Europe to engage with payers, hospital stakeholders, policymakers, and KOL
Responsibilities
- Develop the market access strategy for the France-BENELUX cluster in line with the global market access strategy, for the products marketed within the cluster.
- Ensure a successful evaluation by the agencies responsible for HTA (Health Technology Assessment) across all countries in the cluster; Act as the point of contact for health authorities regarding HTA evaluation; Shape and influence HTA outcomes through: Robust evidence strategies, early engagement with stakeholders.
- Drive development of budget impact models to demonstrate therapy value and assess the budgetary impact in line with the Cluster’s needs.
- Lead high-stakes pricing negotiations with authorities (e.g., CEPS). Ensure alignment between value proposition, clinical evidence, and pricing ambition .
- Provide strategic guidance on innovative funding approaches and access models
- Build and maintain high-level relationships with: Government authorities and payers, key opinion leaders and medical societies, patient associations and industry trade unions.
- Represent Intuitive in external forums and strategic discussions supporting access of Endoluminal portfolio.
- Drive Intuitive’s reputation as a trusted partner in healthcare transformation
- Integrate real-world insights into Market Access strategies.
- Identify barriers across: Hospital settings, Outpatient / ambulatory care pathways.
- Develop pragmatic, patient-centered access solutions to improve adoption and outcomes.
- Support initiatives that enhance continuity of care and system efficiency from diagnosis to treatment
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
What This Job Offers
Job Type
Full-time
Career Level
Senior
